1. In Vivo

Start-Up Previews (11/03)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, The New Movement in Spine, features profiles of Archus Orthopedics Inc., AxioMed Spine Corp., Gelifex Inc. and Replication Medical Inc. Plus these Start-Ups Across Health Care: Advanced Circulatory Systems Inc., Ambrx Inc., Clearant Inc., Compound Therapeutics Inc., Hydra Biosciences Inc., NanoBio Corp., Phenomix Corp. and VisEn Medical Inc.

A preview of the emerging health care companies profiled in the current issue of START-UP: Windhover's Review of Emerging Medical Ventures

Archus Orthopedics Inc. has developed a prosthetic device to replace the spine's natural facet joints that regulate tortional motion...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from In Vivo

Podcast: Acuitas CSO On CRISPR Delivery Breakthrough And Next-Gen Lipid Nanoparticle Technology

 
• By David Wild

In Vivo sits down with Ying Tam, CSO at Acuitas Therapeutics, to discuss the company's role in delivering the first personalized CRISPR treatment to an infant and the clinical implications of new lipid nanoparticle technologies.

BioBytes: AI-Related Deals In Q2 ‘25

 
• By David Wild

When it came to AI-related deals, the second quarter of 2025 was characterized by mostly modest financings.

Titans Of Pharma: Lilly’s Ricks Tops Big Pharma Pay Chart

 
• By Eleanor Malone, Edwin Elmhirst, and Kosh Naran

The big pharma CEO with the highest-valued compensation in 2024 was David Ricks of Eli Lilly, while Pfizer and J&J executives slipped into third and fourth place behind AbbVie's now retired chief Richard Gonzalez. European firms brought up the rear.